Press Releases
20202019201820172016201520142013
29 Oct, 2020
BioLight reports investment agreement and a manufacturing agreement in the subsidiary DiagnosTear
BioLight reports investment agreement and a manufacturing agreement in the subsidiary DiagnosTear
1 Jul, 2019
Third stage of the binding agreement of investment in and acquisition in stages of IOPtima
Third stage of the binding agreement of investment in and acquisition in stages of IOPtima
17 Apr, 2019
DiagnosTear Ltd. – CE Mark Approval
DiagnosTear Ltd. – CE Mark Approval
27 Sep, 2018
Closing of the second stage of the binding agreement of investment in and acquisition in stages of IOPtima
Closing of the second stage of the binding agreement of investment in and acquisition in stages of IOPtima
10 May, 2018
Rights Offering Results
Rights Offering Results
5 Apr, 2016
BioLight Reports 2015 Financial Results
BioLight Reports 2015 Financial Results
8 Dec, 2015
First IOPtiMate™ System Sale in Portugal
First IOPtiMate™ System Sale in Portugal
1 Dec, 2015
Third Quarter 2015 Financial Results
Third Quarter 2015 Financial Results
25 Nov, 2015
Joint Investment in IOPtima Subsidiary
Joint Investment in IOPtima Subsidiary
30 Sep, 2015
IOPtima - Issuance of Israeli Patent
IOPtima - Issuance of Israeli Patent
31 Aug, 2015
Second Quarter 2015 Financial Results
Second Quarter 2015 Financial Results
31 Aug, 2015
Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ
Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ
13 Aug, 2015
First IOPtiMate™ System Sale in Peru
First IOPtiMate™ System Sale in Peru
15 Jun, 2015
Collaboration with Ora, Inc. for TeaRx™
Collaboration with Ora, Inc. for TeaRx™
1 Jun, 2015
First Quarter 2015 Financial Results
First Quarter 2015 Financial Results
1 Jun, 2015
IOPtima - Issuance of Japanese Patent
IOPtima - Issuance of Japanese Patent
13 Apr, 2015
First IOPtiMate™ System Sale in Hungary
First IOPtiMate™ System Sale in Hungary
11 Feb, 2015
IOPtima - Issuance of Chinese Patent
IOPtima - Issuance of Chinese Patent
1 Feb, 2015
IOPtima - Issuance of Israeli Patent
IOPtima - Issuance of Israeli Patent
27 Nov, 2014
First IOPtiMate™ System Sale in Poland
First IOPtiMate™ System Sale in Poland
22 Oct, 2014
BioLight to Present at the Canaccord Forum
BioLight to Present at the Canaccord Forum
13 Oct, 2014
IOPtima will Present at the OIS Conference
IOPtima will Present at the OIS Conference
9 Sep, 2014
First IOPtiMate™ System Sale in Hong Kong
First IOPtiMate™ System Sale in Hong Kong
2 Jul, 2014
Issuance of U.S. Patent for the Long-Term Controlled-Release Drug-Delivery Insert Platform
Issuance of U.S. Patent for the Long-Term Controlled-Release Drug-Delivery Insert Platform
14 May, 2014
U.S. Patent Approval for its Formulation of Latanoprost in its Proprietary Controlled Release Insert
U.S. Patent Approval for its Formulation of Latanoprost in its Proprietary Controlled Release Insert
31 Mar, 2014
IND Filing to FDA for Phase I/IIa Clinical Trial for its Controlled-Release Latanaprost Insert
IND Filing to FDA for Phase I/IIa Clinical Trial for its Controlled-Release Latanaprost Insert
19 Mar, 2014
BioLight Announces New Insider
BioLight Announces New Insider
6 Mar, 2014
BioLight Raises NIS 19 Million
BioLight Raises NIS 19 Million
27 Feb, 2014
BioLight to Present at 26th Annual ROTH Conference
BioLight to Present at 26th Annual ROTH Conference
27 Feb, 2014
Meeting Summons - March 2014
Meeting Summons - March 2014
20 Feb, 2014
BioLight Begins Trading on OTCQX®
BioLight Begins Trading on OTCQX®
10 Feb, 2014
DiagnosTear Starts Clinical Study
DiagnosTear Starts Clinical Study
3 Feb, 2014
Micromedic Reports Success in Pilot in China
Micromedic Reports Success in Pilot in China
31 Dec, 2013
IOPtima Sigend a Distribution Agreement in Taiwan
IOPtima Sigend a Distribution Agreement in Taiwan
28 Aug, 2013
BioLight Will Work to Register ADR in the US
BioLight Will Work to Register ADR in the US
17 Jul, 2013
Marketing Approval for the IOPtiMate™ in Mexico
Marketing Approval for the IOPtiMate™ in Mexico
20 Jan, 2013
Investment in DES Diagnostics
Investment in DES Diagnostics